Pseudomonas Aeruginosa Treatment

Hand soap recalled in Canada and the United States for bacterial problem    Sacramento Bee

Lisa Smyth: Eleventh hour discovery points to serious lack of preparedness    Belfast Telegraph

Face mask hygiene: how dirty is yours?    Telegraph.co.uk

Intravesical Phage Therapy May Treat UTI in Men Undergoing TURP    Infectious Disease Advisor

Merck to Present New Data from its Extensive Infectious Diseases and Vaccines Pipeline and Portfolio During IDWeek 2020    The Baytown Sun

EPA’s Draft Residual Efficacy Protocols for “Long-Lasting” Efficacy for Antiviral Products    JD Supra

EPA’s Draft Residual Efficacy Protocols for “Long-Lasting” Efficacy for Antiviral Products    JD Supra

Intravesical Phage Therapy May Treat UTI in Men Undergoing TURP    Renal and Urology News

Intravesical Phage Therapy May Treat UTI in Men Undergoing TURP    Renal and Urology News

Intravesical Phage Therapy May Treat UTI in Men Undergoing TURP    Renal and Urology News

Minimal CRISPR-Cas3 System Makes Substantial Deletions    Genetic Engineering & Biotechnology News

New DNA-cutting tool could advance gene editing for novel treatments    News-Medical.net

Aridis Pharmaceuticals Reports Positive Preclinical Efficacy Data of a Highly Effective Inhaled Treatment Supporting a Proposed Self-Administered Therapy for COVID-19 Patients    PRNewswire

Intravesical Phage Therapy May Treat UTI in Men Undergoing TURP    Renal and Urology News

Mammalian lipid droplets are innate immune hubs integrating cell metabolism and host defense    Science Magazine

CRISPR Meets Pac-Man: New DNA Cut-and-Paste Tool Enables Bigger Gene Edits    UCSF News Services

CRISPR Meets Pac-Man: New DNA Cut-and-Paste Tool Enables Bigger Gene Edits    UCSF News Services

Trial of Oral CB-280 for Chronic Lung Infections in CF Enrolling...    Cystic Fibrosis News Today

Entasis Therapeutics Highlights Multiple Data Presentations at Virtual ID Week    Yahoo Finance

Mammalian lipid droplets are innate immune hubs integrating cell metabolism and host defense    Science Magazine

Shionogi Announces Publication of Two Studies in The Lancet Infectious Diseases Highlighting the Efficacy and Safety of FETROJA® for the Treatment of Infections Due to Aerobic Gram-negative Bacteria in Adults With Limited Treatment Options    DutchNews.nl

Mammalian lipid droplets are innate immune hubs integrating cell metabolism and host defense    Science Magazine

Shionogi Announces Publication of Two Studies in The Lancet Infectious Diseases Highlighting the Efficacy and Safety of FETROJA® for the Treatment of Infections Due to Aerobic Gram-negative Bacteria in Adults With Limited Treatment Options    Business Wire

Aridis Pharmaceuticals Announces $8.5 Million Registered Direct Offering | News    WFMZ Allentown

Mechanical forces of biofilms could play role in infections    Science Daily

Shionogi Announces Publication of Two Studies in The Lancet Infectious Diseases Highlighting the Efficacy and Safety of FETROJA® for the Treatment of Infections Due to Aerobic Gram-negative Bacteria in Adults With Limited Treatment Options    DutchNews.nl

SHIONOGI ANNOUNCES PUBLICATION OF TWO STUDIES IN THE LANCET INFECTIOUS DISEASES HIGHLIGHTING THE EFFICACY AND SAFETY OF CEFIDEROCOL FOR THE TREATMENT    PharmiWeb.com

IV antibiotics not superior to oral therapy for eradicating P. aeruginosa in cystic fibrosis    Healio

Phase 3 trials show positive results for cefiderocol, but questions remain    CIDRAP

Phase 3 trials show positive results for cefiderocol, but questions remain    CIDRAP

RedHill Biopharma Announces Partnerships to Expand Manufacturing for COVID-19 Therapeutic Candidate Opaganib    StreetInsider.com

Research Roundup: CovidD-19 Pain Relief and More    PharmaLive

Form 6-K RedHill Biopharma Ltd. For: Oct 07    StreetInsider.com

Form 6-K RedHill Biopharma Ltd. For: Oct 07    StreetInsider.com

Form 6-K RedHill Biopharma Ltd. For: Oct 07    StreetInsider.com

Form 6-K RedHill Biopharma Ltd. For: Oct 07    StreetInsider.com

A novel therapeutic approach to resistant superficial dermal infections    Jill Lopez

A novel therapeutic approach to resistant superficial dermal infections    Jill Lopez

A novel therapeutic approach to resistant superficial dermal infections    Jill Lopez

Curetis Receives €350K German Government Grant to Develop Carbapenem Resistance Test    GenomeWeb

Armata Pharmaceuticals to Present at the Virtual 2020 World Antimicrobial Resistance Congress    Monterey County Weekly

OpGen Announces Award of German Government Grant Funding to its Subsidiary Curetis and Collaborators    BioSpace

Armata Pharmaceuticals to Present at the Virtual 2020 World Antimicrobial Resistance Congress    Monterey County Weekly

Mesenchymal stem cells prevent overwhelming inflammation and reduce infection severity via recruiting CXCR3+ regulatory T cells    Wiley

Curetis Receives €350K German Government Grant to Develop Carbapenem Resistance Test    GenomeWeb

Armata Pharmaceuticals to Present at the Virtual 2020 World Antimicrobial Resistance Congress    Monterey County Weekly

Mesenchymal stem cells prevent overwhelming inflammation and reduce infection severity via recruiting CXCR3+ regulatory T cells    Wiley

Mesenchymal stem cells prevent overwhelming inflammation and reduce infection severity via recruiting CXCR3+ regulatory T cells    Wiley